Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pelthos Therapeutics (PTHS) Shares Outstanding (2024 - 2025)

Pelthos Therapeutics has reported Shares Outstanding over the past 2 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $3.2 million for Q4 2025, up 429.9% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (up 429.9% YoY), and the annual figure for FY2025 was $3.2 million, up 429.9%.
  • Shares Outstanding for Q4 2025 was $3.2 million at Pelthos Therapeutics, up from $3.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PTHS hit a ceiling of $3.2 million in Q4 2025 and a floor of $2600.0 in Q1 2024.